Literature DB >> 1974916

Natural autoantibodies to thymocytes: origin, VH genes, fine specificities, and the role of Thy-1 glycoprotein.

K Hayakawa1, C E Carmack, R Hyman, R R Hardy.   

Abstract

15 SM/J mouse hybridoma antibodies that show antithymocyte autoantibody (ATA) activity by immunofluorescence staining were studied. Half of these antibodies react with determinants whose expression is associated with Thy-1, as shown by blocking experiments with anti-Thy-1 and loss of reactivity with Thy-1- mutant cell lines. The Thy-1 dependence of three of these ATA is further confirmed by their reexpression on a Thy-1 gene transfectant. However, the remaining antibodies exhibited binding that showed little or no dependence on Thy-1. Furthermore, we find that most ATA derives from the Ly-1 B subpopulation, as demonstrated by lipopolysaccharide-induced ATA secretion in vitro and by comparison of ATA hybridoma frequencies. VH region gene sequence data of 14 monoclonal ATA from Ly-1 B cell-derived hybridomas reveal the utilization of nine VH genes belonging to four different VH families (J558, 3609, Q52, and Vgam3.8). While we find that two of these hybridomas arose from a clonal expansion, we also find four examples of a 3609 family VH gene utilized in clonally independent lines showing similar specificity. Yet another example of identical VH gene usage by clonally unrelated cells is found in two J558 ATA of a distinct fine specificity. These data suggest that the enrichment of ATA B cells in the Ly-1 B subset is primarily due to repeated independent recruitment of B cells by antigen resulting in the expression of a restricted set of VH genes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974916      PMCID: PMC2188561          DOI: 10.1084/jem.172.3.869

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  ANTINUCLEAR FACTOR IN MICE.

Authors:  L C NORINS; M C HOLMES
Journal:  J Immunol       Date:  1964-07       Impact factor: 5.422

2.  Immunofluorescence studies on thymocytotoxic antibody from New Zealand Black mice.

Authors:  L M Parker; T M Chused; A D Steinberg
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

3.  Complementation patterns of Thy-1 variants and evidence that antigen loss variants "pre-exist" in the parental population.

Authors:  R Hyman; V Stallings
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

4.  Naturally occurring cytotoxic anti-tumour antibodies in sera of congenitally athymic (nude) mice.

Authors:  W J Martin; S E Martin
Journal:  Nature       Date:  1974-06-07       Impact factor: 49.962

5.  Thymus reactive IgM autoantibodies in normal mouse sera.

Authors:  W J Martin; S E Martin
Journal:  Nature       Date:  1975-04-24       Impact factor: 49.962

6.  Differential cytotoxic effect of natural thymocytotoxic autoantibody of NZB mice on functional subsets of T cells.

Authors:  T Shirai; K Hayakawa; K Okumura; T Tada
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

7.  Large numbers of cells in normal mice produce antibody components of isologous erythrocytes.

Authors:  A J Cunningham
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

8.  Spontaneous occurrence of autoantibodies cytotoxic to thymus cells in the sera of mice of the 129 strain.

Authors:  M Schlesinger
Journal:  Nature       Date:  1965-07-24       Impact factor: 49.962

9.  The synthesis and properties of T25 blycoprotein in Thy-1-negative mutant lymphoma cells.

Authors:  I S Trowbridge; R Hyman; C Mazauskas
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

10.  Chemical characterisation of the Thy-1 glycoproteins from the membranes of rat thymocytes and brain.

Authors:  A N Barclay; M Letarte-Muirhead; A F Williams; R A Faulkes
Journal:  Nature       Date:  1976-10-14       Impact factor: 49.962

View more
  23 in total

Review 1.  CD5, an important regulator of lymphocyte selection and immune tolerance.

Authors:  Chander Raman
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.

Authors:  M T Kasaian; H Ikematsu; P Casali
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

3.  A developmental switch in B lymphopoiesis.

Authors:  R R Hardy; K Hayakawa
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 4.  Development of B cells producing natural autoantibodies to thymocytes and senescent erythrocytes.

Authors:  Richard R Hardy; Kyoko Hayakawa
Journal:  Springer Semin Immunopathol       Date:  2004-12-21

5.  Developmental expression of B cell molecules in equine lymphoid tissues.

Authors:  J M B Prieto; R L Tallmadge; M J B Felippe
Journal:  Vet Immunol Immunopathol       Date:  2016-12-13       Impact factor: 2.046

Review 6.  A Hard(y) Look at B-1 Cell Development and Function.

Authors:  Nicole Baumgarth
Journal:  J Immunol       Date:  2017-11-15       Impact factor: 5.422

7.  Natural anti-intestinal goblet cell autoantibody production from marginal zone B cells.

Authors:  Daiju Ichikawa; Masanao Asano; Susan A Shinton; Joni Brill-Dashoff; Anthony M Formica; Anna Velcich; Richard R Hardy; Kyoko Hayakawa
Journal:  J Immunol       Date:  2014-12-05       Impact factor: 5.422

Review 8.  Perspectives on fetal derived CD5+ B1 B cells.

Authors:  Richard R Hardy; Kyoko Hayakawa
Journal:  Eur J Immunol       Date:  2015-09-23       Impact factor: 5.532

9.  Autoreactive B-1 B cells: constraints on natural autoantibody B cell antigen receptors.

Authors:  Ben Rowley; Lingjuan Tang; Susan Shinton; Kyoko Hayakawa; Richard R Hardy
Journal:  J Autoimmun       Date:  2007-09-21       Impact factor: 7.094

10.  Monoclonal immunoglobulin A derived from peritoneal B cells is encoded by both germ line and somatically mutated VH genes and is reactive with commensal bacteria.

Authors:  N A Bos; J C Bun; S H Popma; E R Cebra; G J Deenen; M J van der Cammen; F G Kroese; J J Cebra
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.